Simponi 50 mg/0.5 mL single-dose prefilled SmartJect® autoinjector Images
Generic Name: golimumab
This medication has been identified as Simponi 50 mg/0.5 mL single-dose prefilled SmartJect® autoinjector. It is supplied by Janssen Biotech, Inc.
Simponi is used in the treatment of Ankylosing Spondylitis; Psoriatic Arthritis; Rheumatoid Arthritis; Spondyloarthritis; Ulcerative Colitis and belongs to the drug class TNF alfa inhibitors. There is no proven risk in humans during pregnancy. Simponi 50 mg/0.5 mL single-dose prefilled SmartJect® autoinjector is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Simponi
- Generic Name
- golimumab
- Strength
- 50 mg/0.5 mL single-dose prefilled SmartJect® autoinjector
- Availability
- Prescription only
- Drug Class
- TNF alfa inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Biotech, Inc.
- National Drug Code (NDC)
- 57894-0070
More about Simponi (golimumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (114)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
